Envisioning trans-inclusive and trans-specific cancer care

Transgender patients are a marginalized group for whom current standards of oncology have yet to be optimized. In this Comment, we highlight opportunities for transgender-inclusive and transgender-specific practices across the cancer care continuum and identify evidence gaps that will need to be filled to attain optimal care for transgender populations.

Automated summary

Transgender patients are marginalized and current oncology standards need improvement. This Comment highlights the need for inclusive and specific practices in cancer care for transgender populations while identifying evidence gaps.